Moderna accuses Pfizer/BioNTech of patent infringement

The American biotechnology company Moderna announced Friday to file a complaint once morest Pfizer and BioNTech. She accuses them of the violation of patents concerning their messenger RNA vaccine once morest Covid-19.

“Moderna is satisfied that Pfizer and BioNTech’s Comirnaty Covid-19 vaccine infringes patents filed by Moderna between 2010 and 2016 covering Moderna’s fundamental messenger RNA technology,” said a statement from the firm. Moderna and Pfizer/BioNTech were the first to put their coronavirus vaccines into production, very soon following the start of the pandemic.

Messenger RNA technology can command human cells to make proteins present in the virus in order to train the immune system to recognize and neutralize it. Until then, vaccines relied on weakened or inactivated forms of the virus to train the body to defend itself, and the development of remedies, as well as clinical trials to verify their safety, might take several years.

The use of messenger RNA technology in Moderna and Pfizer/BioNTech’s vaccines, among the most injected in the world, was the culmination of four decades of research that has overcome many obstacles. ‘This breakthrough technology was crucial to the development of Moderna’s own messenger RNA vaccine, Spikevax. Pfizer and BioNTech copied this technology, without Moderna’s permission, to manufacture Comirnaty’, Moderna’s press release adds.

/ATS

Share:

Facebook
Twitter
Pinterest
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.